bulletinhistoryconnectmaincategories
missionhelpchatblogs

Singapura Finance Reports Full Year 2024 Financial Results

February 27, 2025 - 05:59

Singapura Finance Reports Full Year 2024 Financial Results

Singapura Finance has announced its financial results for the full year 2024, revealing a slight decline in earnings per share (EPS) at S$0.038, compared to S$0.039 in the previous fiscal year. Despite this decrease in EPS, the company demonstrated a positive trend in revenue, which rose to S$23.7 million, marking an increase of 8.5% from FY 2023.

The growth in revenue reflects the company's ongoing efforts to enhance its service offerings and expand its customer base. The financial results indicate a resilient performance amid challenging market conditions. Additionally, the company has been focusing on optimizing its operations to improve efficiency and profitability.

Looking ahead, Singapura Finance is optimistic about its growth prospects. The management is committed to implementing strategic initiatives aimed at sustaining revenue growth and enhancing shareholder value. This results announcement underscores the company's dedication to navigating the evolving financial landscape while maintaining a strong operational foundation.


MORE NEWS

Is PDD Holdings Inc. (PDD) A Good Stock To Buy Now?

June 8, 2026 - 04:51

Is PDD Holdings Inc. (PDD) A Good Stock To Buy Now?

A recent discussion on a value investing forum laid out a bullish case for PDD Holdings Inc., the parent company of e-commerce platforms Temu and Pinduoduo. As of late May, shares were trading near...

Apple Stock: Buy, Sell, or Hold?

June 7, 2026 - 03:13

Apple Stock: Buy, Sell, or Hold?

Apple`s stock is trading close to an all-time high, and a series of potential catalysts could sustain the upward momentum. The company continues to benefit from strong demand for its latest iPhone...

Eli Lilly's $3.8 Billion Vaccine Bets: Here's the Big Story Many Investors Are Missing

June 6, 2026 - 22:38

Eli Lilly's $3.8 Billion Vaccine Bets: Here's the Big Story Many Investors Are Missing

Eli Lilly is making a serious push into the vaccine business. The pharmaceutical giant announced a trio of acquisitions totaling $3.8 billion, aimed at building a new division focused on infectious...

Are US Treasuries becoming a financial chokepoint?

June 6, 2026 - 12:16

Are US Treasuries becoming a financial chokepoint?

For decades, US government bonds were the bedrock of global finance. Investors bought them during crises, banks used them as collateral, and central banks held them as reserves. But a growing...

read all news
bulletinhistoryconnectmaincategories

Copyright © 2026 Coinlyt.com

Founded by: Eric McGuffey

missionhelpchatpicksblogs
data policycookiesterms of use